Combination therapy shows promise for treatment-resistant inflammatory bowel disease

Patients with severe IBD face repeated surgeries and permanent bowel damage; one patient profiled has undergone 20 abdominal surgeries since age 7.

For the millions living with inflammatory bowel disease — and especially for the fraction whose bodies have resisted every available treatment — medicine has long offered diminishing returns and, eventually, the surgeon's knife. Two clinical trials now suggest that pairing two already-approved drugs may open a door that had seemed permanently closed, nearly doubling remission rates for the most treatment-exhausted patients. The findings do not yet constitute a cure, nor are they the final word, but they represent something rarer in chronic illness: a credible reason for hope grounded in rigoro

Combination therapy shows promise for treatment-resistant inflammatory bowel disease

Cobertura Relacionada

Receba o Register no seu e-mail